On June 26, 2025, Lexeo Therapeutics, Inc. held its Annual Meeting of Stockholders, where they elected two Class II Directors and ratified KPMG LLP as their independent accounting firm for 2025. The vote counts were 19,800,126 for Steven Altschuler and 19,986,796 for Reinaldo Diaz, while 27,929,327 stockholders supported the appointment of KPMG.